Nephrotoxicity
This medicine may affect the kidneys.
Medicine information EMTRICITABINA/TENOFOVIR DISOPROXIL STADA 200mg / 245mg film-coated tablets
- Product code:
- W66839001
- Quantity:
- 30
- Indicated for:
- HIV-1 infection
- Route of administration:
- oral
- Substance:
- emtricitabine + tenofovir disoproxil (nucleoside/nucleotide reverse transcriptase inhibitor+antiretroviral)
- ATC
- J05AR03 — Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations
The combination of emtricitabine and tenofovir disoproxil is used for the treatment of HIV infection and for pre-exposure prophylaxis (PrEP). It works by inhibiting reverse transcriptase, preventing HIV replication.
The medication is taken orally, usually once daily, with the dose adjusted based on the patient's weight and renal function. Common side effects include nausea, diarrhea, headaches, and decreased bone mineral density.
This combination is contraindicated in patients with severe renal impairment or hypersensitivity to any of the components. Its use also requires regular monitoring of renal function and bone density.
This medication is an effective option for managing HIV infection and preventing virus transmission, helping to improve patients' quality of life.
The medication is taken orally, usually once daily, with the dose adjusted based on the patient's weight and renal function. Common side effects include nausea, diarrhea, headaches, and decreased bone mineral density.
This combination is contraindicated in patients with severe renal impairment or hypersensitivity to any of the components. Its use also requires regular monitoring of renal function and bone density.
This medication is an effective option for managing HIV infection and preventing virus transmission, helping to improve patients' quality of life.
General data about EMTRICITABINA/TENOFOVIR DISOPROXIL STADA 200mg / 245mg
- Substance:
- emtricitabine + tenofovir disoproxil
- Date of latest medicines list:
- 01-10-2026
- Product code:
- W66839001
- Strength:
- 200mg / 245mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 30
- Product type:
- Generic medicine
- Price:
- 452.55 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Combinations with other substances
Official documents
Professional information (SmPC) - Romanian
Patient leaflet - Romanian
Packaging and labelling information - Romanian
The correspondence between the document and the displayed text is unconfirmed.
- Source institution
- ANMDMR
- Document language
- Romanian
Warnings:
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Reimbursement lists for EMTRICITABINA/TENOFOVIR DISOPROXIL STADA 200mg / 245mg STADA
NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment
- Price
- 452.55 RON
- Copayment
- 338.05 RON
- Patient payment
- 114.50 RON